Head-to-head randomized trials of atorvastatin and rosuvastatin: a systematic review and meta-analysis of changes in inflammatory biomarkers

11 May 2026 (12:21 - 13:38)
Organised by: Logo
Congress Presentation Part of: ePosters in pharmacology and pharmacotherapy (2) Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by